Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Prepaid Assets (2019 - 2025)

Silence Therapeutics' Prepaid Assets history spans 6 years, with the latest figure at $11.5 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 21.32% year-over-year to $11.5 million; the TTM value through Dec 2025 reached $11.5 million, down 21.32%, while the annual FY2025 figure was $11.5 million, 21.32% down from the prior year.
  • Prepaid Assets for Q4 2025 was $11.5 million at Silence Therapeutics, up from $9.3 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $14.7 million in Q4 2024 and bottomed at $5.8 million in Q4 2021.
  • The 5-year median for Prepaid Assets is $10.6 million (2022), against an average of $10.4 million.
  • The largest annual shift saw Prepaid Assets skyrocketed 65.58% in 2022 before it fell 21.32% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $5.8 million in 2021, then surged by 65.58% to $9.6 million in 2022, then grew by 20.92% to $11.6 million in 2023, then increased by 26.09% to $14.7 million in 2024, then fell by 21.32% to $11.5 million in 2025.
  • Per Business Quant, the three most recent readings for SLN's Prepaid Assets are $11.5 million (Q4 2025), $9.3 million (Q3 2025), and $14.7 million (Q4 2024).